New partnership advances medical isotope technology

McMaster University and Promation have signed a Memorandum of Understanding (MoU) to work together to bring a new medical isotope technology developed at McMaster to the marketplace. At the center of this collaboration is a new technology for producing lutetium-177 (Lu-177), an increasingly sought-after medical isotope. Clinical trials have shown that Lu-177-based drugs have tremendous … Read more

CNIC signs historic MOU to collaborate on the 11th International Conference on Isotopes

TORONTO – May 12 , 2021  –The Canadian Nuclear Isotope Council (CNIC)  and the Local Organizing Committee of the 11th International Conference on Isotopes (11ICI) have entered into a Memorandum of Understanding to co-promote and support the conference’s success in 2022. The 11ICI will be  hosted by Sylvia Fedoruk Canadian Centre for Nuclear Innovation in … Read more

BWXT Medical Enters into a New Long-Term Agreement with Boston Scientific

(Ottawa, Ontario – May 10, 2021) – BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company. Developed for the treatment of patients with hepatocellular carcinoma (HCC), TheraSphere treatment is comprised of millions … Read more

Event: Welcome to the CARI Program and Overcoming Commercialization Challenges in the Canadian Isotope Sector, June 23 2021

Welcome to the CARI Program and Overcoming Commercialization Challenges in the Canadian Isotope Sector Wednesday June 23, 11:00 a.m. – 12:00 p.m. CARI is a collaboration between The Centre for Probe Development and Commercialization (CPDC) and adMare BioInnovations (adMare) working to bring respective resources together to advance an area of tremendous therapeutic and commercial potential … Read more

Event: Innovation, Automation and the Digital Transformation of the Canadian Isotope Sector, May 12 2021

Innovation, Automation and the Digital Transformation of the Canadian Isotope Sector Wednesday May 12, 11:00 a.m. – 12:00 p.m. This event will explore the interdisciplinary partnerships in Canada’s domestic isotope supply chain that are enabling new and innovative patient treatments and increasing the efficiency, ease, and safety of the isotope production, packaging and delivery processes. … Read more

New report shines spotlight on Canadian isotope excellence

Medical isotope ecosystem directory details tremendous capabilities of Canada’s isotope industry.   Today, the Organization of Canadian Nuclear Industries (OCNI) and the Canadian Nuclear Isotope Council (CNIC) released the Canadian Medical Isotope Ecosystem Directory. The directory demonstrates the capabilities of the Canadian isotope sector companies and their leading international expertise as well as highlights the … Read more

Canada is an Isotope Superpower

On the CNIC’s 3rd birthday we highlight why the isotope sector is key contributor to economic recovery. The importance of nuclear medicine and medical isotopes in our daily lives — and Canada’s global leadership position in this sector — admittedly flies under the radar for most people, and their significance has never been more vital … Read more

Storied Canadian manufacturer, Advanced Cyclotron Systems, joins the CNIC

TORONTO – March 31, 2021 – Advanced Cyclotron Systems Inc. (ACSI), a world leader in the design and manufacturing of cyclotron equipment, including PET and SPECT radioisotope production cyclotrons, will join the Canadian Nuclear Isotope Council (CNIC), further cementing the industry association as the pre-eminent representative of the Canadian Isotope sector. “Over the past two-and-half … Read more